Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

University of Miami Health System, Miami, Florida

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Vanderbilt University, Nashville, Tennessee